ID: ALA1760430

Max Phase: Preclinical

Molecular Formula: C25H20N2O4

Molecular Weight: 412.45

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COC(=O)c1ccc(-c2c3cccc(OC)c3nc3c2[nH]c2c(OC)cccc23)cc1

Standard InChI:  InChI=1S/C25H20N2O4/c1-29-18-8-4-6-16-20(14-10-12-15(13-11-14)25(28)31-3)24-23(26-21(16)18)17-7-5-9-19(30-2)22(17)27-24/h4-13,27H,1-3H3

Standard InChI Key:  SQTAVXTVQDOFPI-UHFFFAOYSA-N

Associated Targets(Human)

5637 630 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

RT-4 268 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

A-427 643 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

DAN-G 242 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MCF7 126967 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 412.45Molecular Weight (Monoisotopic): 412.1423AlogP: 5.34#Rotatable Bonds: 4
Polar Surface Area: 73.44Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.28CX Basic pKa: 2.93CX LogP: 4.97CX LogD: 4.97
Aromatic Rings: 5Heavy Atoms: 31QED Weighted: 0.40Np Likeness Score: -0.02

References

1. Riechert-Krause F, Eick A, Grünert R, Bednarski PJ, Weisz K..  (2011)  In vitro anticancer activity and evaluation of DNA duplex binding affinity of phenyl-substituted indoloquinolines.,  21  (8): [PMID:21414783] [10.1016/j.bmcl.2011.02.088]

Source